A focus on medical device regulation in the UK after Brexit, a regulatory country overview on Peru, reusable ophthalmic devices, views on biological evaluation from the Italian AFI Regulatory Affairs Working Group, the regulation of SaMD in the USA, and much more now available in the November 2020 edition of the Journal of Medical Device Regulation
London, 10 November 2020 – The Journal of Medical Device Regulation releases today the contents of its November 2020 issue to non-subscribing readers.
The following articles are now publicly available through the Journal’s website – GlobalRegulatoryPress.com – 10 days after their official publication in the Journal:
- Understanding the medical device regulatory regime in Great Britain and Northern Ireland after 31 December 2020 (end of Brexit transition period)
- The Biological Evaluation Plan: An approach to the biological evaluation of medical devices with a focus on substance-based medical devices
- The evolving regulation of software as a medical device in the USA
- Reprocessing of reusable ophthalmic devices
- An overview of the regulatory requirements that apply to medical devices and IVDs in Peru
About the Journal of Medical Device Regulation
The Journal of Medical Device Regulation (founded in 2004) reaches regulatory professionals around the world and provides them with in-depth articles on current regulatory matters as well as topical information on international regulatory changes. In addition to publishing review and discussion articles by opinion leaders from the device community, the Journal summarises the global news headlines and provides useful reference information in the form of charts and briefing documents. The Journal is a quarterly, subscription-only publication that is available in electronic format.
For more information on the Journal of Medical Device Regulation, please contact us (tel: +44 7916 443811), email: sales@globalregulatorypress.com) or visit GlobalRegulatoryPress.com.
